Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 43 of 43 entries
Sorted by: Best Match Show Resources per page
Reproducibility of myocardial perfusion reserve - variations in measurements from post processing using commercially available software.

Cardiovascular diagnosis and therapy

Goykhman P, Mehta PK, Agarwal M, Shufelt C, Slomka PJ, Yang Y, Xu Y, Shaw LJ, Berman DS, Merz NB, Thomson LE.
PMID: 24282727
Cardiovasc Diagn Ther. 2012 Dec;2(4):268-77. doi: 10.3978/j.issn.2223-3652.2012.10.02.

PURPOSE: Adenosine stress first pass cardiac magnetic resonance imaging (CMRI) is a rapidly evolving tool in the diagnosis of ischemic heart disease (IHD). The rest and stress first pass myocardial perfusion data may be interpreted using commercially available software...

Cite
Goykhman P, Mehta PK, Agarwal M, et al. Reproducibility of myocardial perfusion reserve - variations in measurements from post processing using commercially available software. Cardiovasc Diagn Ther. 2012;2(4):268-77doi: 10.3978/j.issn.2223-3652.2012.10.02.
Goykhman, P., Mehta, P. K., Agarwal, M., Shufelt, C., Slomka, P. J., Yang, Y., Xu, Y., Shaw, L. J., Berman, D. S., Merz, N. B., & Thomson, L. E. (2012). Reproducibility of myocardial perfusion reserve - variations in measurements from post processing using commercially available software. Cardiovascular diagnosis and therapy, 2(4), 268-77. https://doi.org/10.3978/j.issn.2223-3652.2012.10.02
Goykhman, Pavel, et al. "Reproducibility of myocardial perfusion reserve - variations in measurements from post processing using commercially available software." Cardiovascular diagnosis and therapy vol. 2,4 (2012): 268-77. doi: https://doi.org/10.3978/j.issn.2223-3652.2012.10.02
Goykhman P, Mehta PK, Agarwal M, Shufelt C, Slomka PJ, Yang Y, Xu Y, Shaw LJ, Berman DS, Merz NB, Thomson LE. Reproducibility of myocardial perfusion reserve - variations in measurements from post processing using commercially available software. Cardiovasc Diagn Ther. 2012 Dec;2(4):268-77. doi: 10.3978/j.issn.2223-3652.2012.10.02. PMID: 24282727; PMCID: PMC3839165.
Copy Download .nbib Format: NLM
Inter-scan Reproducibility of Cardiovascular Magnetic Resonance Imaging-Derived Myocardial Perfusion Reserve Index in Women with no Obstructive Coronary Artery Disease.

Current trends in clinical & medical imaging

Al-Badri A, Wei J, Landes S, Motwani M, Cook-Wiens G, Nelson MD, Mehta PK, Shufelt C, Sharif B, Li D, Berman DS, Thomson LE, Merz CNB.
PMID: 30976755
Curr Trends Clin Med Imaging. 2018;2(3). doi: 10.19080/CTCMI.2018.02.555587. Epub 2018 Feb 23.

BACKGROUND: Cardiovascular magnetic resonance imaging (CMRI) derived myocardial perfusion reserve index (MPRI) has recently been shown to detect coronary microvascular dysfunction (CMD) in women with signs and symptoms of ischemia and no obstructive coronary artery disease (CAD). The aim...

Cite
Al-Badri A, Wei J, Landes S, et al. Inter-scan Reproducibility of Cardiovascular Magnetic Resonance Imaging-Derived Myocardial Perfusion Reserve Index in Women with no Obstructive Coronary Artery Disease. Curr Trends Clin Med Imaging. 2018;2(3)doi: 10.19080/CTCMI.2018.02.555587.
Al-Badri, A., Wei, J., Landes, S., Motwani, M., Cook-Wiens, G., Nelson, M. D., Mehta, P. K., Shufelt, C., Sharif, B., Li, D., Berman, D. S., Thomson, L. E., & Merz, C. N. B. (2018). Inter-scan Reproducibility of Cardiovascular Magnetic Resonance Imaging-Derived Myocardial Perfusion Reserve Index in Women with no Obstructive Coronary Artery Disease. Current trends in clinical & medical imaging, 2(3), . https://doi.org/10.19080/CTCMI.2018.02.555587
Al-Badri, Ahmed, et al. "Inter-scan Reproducibility of Cardiovascular Magnetic Resonance Imaging-Derived Myocardial Perfusion Reserve Index in Women with no Obstructive Coronary Artery Disease." Current trends in clinical & medical imaging vol. 2,3 (2018). doi: https://doi.org/10.19080/CTCMI.2018.02.555587
Al-Badri A, Wei J, Landes S, Motwani M, Cook-Wiens G, Nelson MD, Mehta PK, Shufelt C, Sharif B, Li D, Berman DS, Thomson LE, Merz CNB. Inter-scan Reproducibility of Cardiovascular Magnetic Resonance Imaging-Derived Myocardial Perfusion Reserve Index in Women with no Obstructive Coronary Artery Disease. Curr Trends Clin Med Imaging. 2018;2(3). doi: 10.19080/CTCMI.2018.02.555587. Epub 2018 Feb 23. PMID: 30976755; PMCID: PMC6455951.
Copy Download .nbib Format: NLM
Physical Activity Associations with Bone Mineral Density and Modification by Metabolic Traits.

Journal of the Endocrine Society

Buttan A, Cui J, Guo X, Chen YI, Hsueh WA, Rotter JI, Goodarzi MO.
PMID: 32803094
J Endocr Soc. 2020 Jul 07;4(8):bvaa092. doi: 10.1210/jendso/bvaa092. eCollection 2020 Aug 01.

OBJECTIVE: To assess the relationship of physical activity with bone mineral density (BMD) at various sites and examine potential modifying metabolic factors.METHODS: Responses from physical activity questionnaires were used to determine total physical activity (PA), moderate physical activity (mod-PA),...

Cite
Buttan A, Cui J, Guo X, et al. Physical Activity Associations with Bone Mineral Density and Modification by Metabolic Traits. J Endocr Soc. 2020;4(8):bvaa092doi: 10.1210/jendso/bvaa092.
Buttan, A., Cui, J., Guo, X., Chen, Y. I., Hsueh, W. A., Rotter, J. I., & Goodarzi, M. O. (2020). Physical Activity Associations with Bone Mineral Density and Modification by Metabolic Traits. Journal of the Endocrine Society, 4(8), bvaa092. https://doi.org/10.1210/jendso/bvaa092
Buttan, Anshu, et al. "Physical Activity Associations with Bone Mineral Density and Modification by Metabolic Traits." Journal of the Endocrine Society vol. 4,8 (2020): bvaa092. doi: https://doi.org/10.1210/jendso/bvaa092
Buttan A, Cui J, Guo X, Chen YI, Hsueh WA, Rotter JI, Goodarzi MO. Physical Activity Associations with Bone Mineral Density and Modification by Metabolic Traits. J Endocr Soc. 2020 Jul 07;4(8):bvaa092. doi: 10.1210/jendso/bvaa092. eCollection 2020 Aug 01. PMID: 32803094; PMCID: PMC7417873.
Copy Download .nbib Format: NLM
Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial.

JMIR research protocols

Birkeland K, Khandwalla RM, Kedan I, Shufelt CL, Mehta PK, Minissian MB, Wei J, Handberg EM, Thomson LE, Berman DS, Petersen JW, Anderson RD, Cook-Wiens G, Pepine CJ, Bairey Merz CN.
PMID: 29263019
JMIR Res Protoc. 2017 Dec 20;6(12):e255. doi: 10.2196/resprot.8057.

BACKGROUND: Digital wearable devices provide a "real-world" assessment of physical activity and quantify intervention-related changes in clinical trials. However, the value of digital wearable device-recorded physical activity as a clinical trial outcome is unknown.OBJECTIVE: Because late sodium channel inhibition...

Cite
Birkeland K, Khandwalla RM, Kedan I, et al. Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial. JMIR Res Protoc. 2017;6(12):e255doi: 10.2196/resprot.8057.
Birkeland, K., Khandwalla, R. M., Kedan, I., Shufelt, C. L., Mehta, P. K., Minissian, M. B., Wei, J., Handberg, E. M., Thomson, L. E., Berman, D. S., Petersen, J. W., Anderson, R. D., Cook-Wiens, G., Pepine, C. J., & Bairey Merz, C. N. (2017). Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial. JMIR research protocols, 6(12), e255. https://doi.org/10.2196/resprot.8057
Birkeland, Kade, et al. "Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial." JMIR research protocols vol. 6,12 (2017): e255. doi: https://doi.org/10.2196/resprot.8057
Birkeland K, Khandwalla RM, Kedan I, Shufelt CL, Mehta PK, Minissian MB, Wei J, Handberg EM, Thomson LE, Berman DS, Petersen JW, Anderson RD, Cook-Wiens G, Pepine CJ, Bairey Merz CN. Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial. JMIR Res Protoc. 2017 Dec 20;6(12):e255. doi: 10.2196/resprot.8057. PMID: 29263019; PMCID: PMC5752966.
Copy Download .nbib Format: NLM
Data from subjects receiving intrathecal laronidase for cervical spinal stenosis due to mucopolysaccharidosis type I.

Data in brief

Dickson PI, Kaitila I, Harmatz P, Mlikotic A, Chen AH, Victoroff A, Passage MB, Madden J, Le SQ, Naylor DE.
PMID: 26484358
Data Brief. 2015 Aug 20;5:71-6. doi: 10.1016/j.dib.2015.08.004. eCollection 2015 Dec.

Five subjects with mucopolysaccharidosis type I and symptomatic cervical spinal stenosis received intrathecal laronidase in a 4-month pilot study and/or a 12-month extension study [1]. Clinical descriptions of study subjects, nonserious adverse events, individual data tables, and scoring system...

Cite
Dickson PI, Kaitila I, Harmatz P, et al. Data from subjects receiving intrathecal laronidase for cervical spinal stenosis due to mucopolysaccharidosis type I. Data Brief. 2015;5:71-6doi: 10.1016/j.dib.2015.08.004.
Dickson, P. I., Kaitila, I., Harmatz, P., Mlikotic, A., Chen, A. H., Victoroff, A., Passage, M. B., Madden, J., Le, S. Q., Naylor, D. E. (2015). Data from subjects receiving intrathecal laronidase for cervical spinal stenosis due to mucopolysaccharidosis type I. Data in brief, 571-6. https://doi.org/10.1016/j.dib.2015.08.004
Dickson, P I, et al. "Data from subjects receiving intrathecal laronidase for cervical spinal stenosis due to mucopolysaccharidosis type I." Data in brief vol. 5 (2015): 71-6. doi: https://doi.org/10.1016/j.dib.2015.08.004
Dickson PI, Kaitila I, Harmatz P, Mlikotic A, Chen AH, Victoroff A, Passage MB, Madden J, Le SQ, Naylor DE. Data from subjects receiving intrathecal laronidase for cervical spinal stenosis due to mucopolysaccharidosis type I. Data Brief. 2015 Aug 20;5:71-6. doi: 10.1016/j.dib.2015.08.004. eCollection 2015 Dec. PMID: 26484358; PMCID: PMC4573094.
Copy Download .nbib Format: NLM
Specialized Proresolving Mediators in Symptomatic Women With Coronary Microvascular Dysfunction (from the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD [WARRIOR] Trial).

The American journal of cardiology

Keeley EC, Li HJ, Cogle CR, Handberg EM, Merz CNB, Pepine CJ.
PMID: 34728061
Am J Cardiol. 2022 Jan 01;162:1-5. doi: 10.1016/j.amjcard.2021.09.015. Epub 2021 Oct 30.

Resolvins and maresins, members of the specialized proresolving mediator (SPM) family, are omega-3 fatty acid-derived lipid mediators that attenuate inflammation. We hypothesized that they play a role in the pathophysiology of coronary microvascular dysfunction (CMD) in women with ischemia...

Cite
Keeley EC, Li HJ, Cogle CR, et al. Specialized Proresolving Mediators in Symptomatic Women With Coronary Microvascular Dysfunction (from the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD [WARRIOR] Trial). Am J Cardiol. 2021;162:1-5doi: 10.1016/j.amjcard.2021.09.015.
Keeley, E. C., Li, H. J., Cogle, C. R., Handberg, E. M., Merz, C. N. B., & Pepine, C. J. (2022). Specialized Proresolving Mediators in Symptomatic Women With Coronary Microvascular Dysfunction (from the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD [WARRIOR] Trial). The American journal of cardiology, 1621-5. https://doi.org/10.1016/j.amjcard.2021.09.015
Keeley, Ellen C, et al. "Specialized Proresolving Mediators in Symptomatic Women With Coronary Microvascular Dysfunction (from the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD [WARRIOR] Trial)." The American journal of cardiology vol. 162 (2022): 1-5. doi: https://doi.org/10.1016/j.amjcard.2021.09.015
Keeley EC, Li HJ, Cogle CR, Handberg EM, Merz CNB, Pepine CJ. Specialized Proresolving Mediators in Symptomatic Women With Coronary Microvascular Dysfunction (from the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD [WARRIOR] Trial). Am J Cardiol. 2022 Jan 01;162:1-5. doi: 10.1016/j.amjcard.2021.09.015. Epub 2021 Oct 30. PMID: 34728061; PMCID: PMC8754056.
Copy Download .nbib Format: NLM
Gene Set Enrichment Analsyes Identify Pathways Involved in Genetic Risk for Diabetic Retinopathy.

American journal of ophthalmology

Sobrin L, Susarla G, Stanwyck L, Rouhana JM, Li A, Pollack S, Igo RP, Jensen RA, Li X, Ng MCY, Smith AV, Kuo JZ, Taylor KD, Freedman BI, Bowden DW, Penman A, Chen CJ, Craig JE, Adler SG, Chew EY, Cotch MF, Yaspan B, Mitchell P, Wang JJ, Klein BEK, Wong TY, Rotter JI, Burdon KP, Iyengar SK, Segrè AV.
PMID: 34166655
Am J Ophthalmol. 2022 Jan;233:111-123. doi: 10.1016/j.ajo.2021.06.014. Epub 2021 Jun 21.

To identify functionally related genes associated with diabetic retinopathy (DR) risk using gene set enrichment analyses applied to genome-wide association study meta-analyses.METHODS: We analyzed DR GWAS meta-analyses performed on 3246 Europeans and 2611 African Americans with type 2 diabetes....

Cite
Sobrin L, Susarla G, Stanwyck L, et al. Gene Set Enrichment Analsyes Identify Pathways Involved in Genetic Risk for Diabetic Retinopathy. Am J Ophthalmol. 2021;233:111-123doi: 10.1016/j.ajo.2021.06.014.
Sobrin, L., Susarla, G., Stanwyck, L., Rouhana, J. M., Li, A., Pollack, S., Igo, R. P., Jensen, R. A., Li, X., Ng, M. C. Y., Smith, A. V., Kuo, J. Z., Taylor, K. D., Freedman, B. I., Bowden, D. W., Penman, A., Chen, C. J., Craig, J. E., Adler, S. G., Chew, E. Y., Cotch, M. F., Yaspan, B., Mitchell, P., Wang, J. J., Klein, B. E. K., Wong, T. Y., Rotter, J. I., Burdon, K. P., Iyengar, S. K., & Segrè, A. V. (2022). Gene Set Enrichment Analsyes Identify Pathways Involved in Genetic Risk for Diabetic Retinopathy. American journal of ophthalmology, 233111-123. https://doi.org/10.1016/j.ajo.2021.06.014
Sobrin, Lucia, et al. "Gene Set Enrichment Analsyes Identify Pathways Involved in Genetic Risk for Diabetic Retinopathy." American journal of ophthalmology vol. 233 (2022): 111-123. doi: https://doi.org/10.1016/j.ajo.2021.06.014
Sobrin L, Susarla G, Stanwyck L, Rouhana JM, Li A, Pollack S, Igo RP, Jensen RA, Li X, Ng MCY, Smith AV, Kuo JZ, Taylor KD, Freedman BI, Bowden DW, Penman A, Chen CJ, Craig JE, Adler SG, Chew EY, Cotch MF, Yaspan B, Mitchell P, Wang JJ, Klein BEK, Wong TY, Rotter JI, Burdon KP, Iyengar SK, Segrè AV. Gene Set Enrichment Analsyes Identify Pathways Involved in Genetic Risk for Diabetic Retinopathy. Am J Ophthalmol. 2022 Jan;233:111-123. doi: 10.1016/j.ajo.2021.06.014. Epub 2021 Jun 21. PMID: 34166655; PMCID: PMC8678352.
Copy Download .nbib Format: NLM
Showing 37 to 43 of 43 entries